{"filing":{"accession_number":"0001104659-26-083274","cik":"0001999480","ticker":"ANRO","company_name":"Alto Neuroscience, Inc.","form":"8-K","filing_date":"2026-07-14","report_date":null,"primary_document":"tm2620328d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1999480/000110465926083274/tm2620328d1_8k.htm"},"events":[{"id":17705,"run_id":15871,"accession_number":"0001104659-26-083274","anchor_item_number":"1.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"Alto Neuroscience entered into an underwriting agreement to issue 3,776,436 shares of common stock in a registered direct offering at $26.48 per share, generating approximately $93.9 million in net proceeds. This is a registered equity issuance that will dilute existing shareholders' ownership and is material to investors assessing the company's capital structure and financing strategy.","company_name":"Alto Neuroscience, Inc.","ticker":"ANRO","filing_date":"2026-07-14","form":"8-K","submitted_at":null,"items":[{"id":16273,"accession_number":"0001104659-26-083274","item_number":"1.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Alto Neuroscience entered into an underwriting agreement to issue 3,776,436 shares of common stock in a registered direct offering at $26.48 per share, generating approximately $93.9 million in net proceeds. This is a registered equity issuance that will dilute existing shareholders' ownership and is material to investors assessing the company's capital structure and financing strategy.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-14T10:06:52.611629+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":16273,"accession_number":"0001104659-26-083274","item_number":"1.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Alto Neuroscience entered into an underwriting agreement to issue 3,776,436 shares of common stock in a registered direct offering at $26.48 per share, generating approximately $93.9 million in net proceeds. This is a registered equity issuance that will dilute existing shareholders' ownership and is material to investors assessing the company's capital structure and financing strategy.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-14T10:06:52.611629+00:00","company_name":"Alto Neuroscience, Inc.","ticker":"ANRO","filing_date":"2026-07-14"}]}